Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC

Introduction: During treatment with immune checkpoint inhibitors, immune-related adverse events sometimes occur, and their management is a critical concern associated with such treatment. Encephalitis and meningitis are some of the critical immune-related adverse events. Atezolizumab is an immune ch...

Full description

Bibliographic Details
Main Authors: Ryo Toyozawa, MD, Naoki Haratake, MD, PhD, Gouji Toyokawa, MD, PhD, Taichi Matsubara, MD, PhD, Shinkichi Takamori, MD, PhD, Naoko Miura, MD, PhD, Masafumi Yamaguchi, MD, PhD, Mitsuhiro Takenoyama, MD, PhD, Takashi Seto, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:JTO Clinical and Research Reports
Subjects:
irAE
Non–small cell lung cancer
Atezolizumab
Aseptic meningitis
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320300126

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320300126

Similar Items